Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphatic Diseases × Daunorubicin × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 35 Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Leukemia 15 Leukemia, Myelomonocytic, Acute 6 Leukemia, Monocytic, Acute 6 Leukemia, Erythroblastic, Acute 6 Burkitt Lymphoma 6 Congenital Abnormalities 5 Leukemia, Megakaryoblastic, Acute 4 Myelodysplastic Syndromes 3 Lymphoma 3 Leukemia, Eosinophilic, Acute 3 Leukemia, Biphenotypic, Acute 3 Recurrence 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Myeloproliferative Disorders 2 Leukemia, Basophilic, Acute 2 Hematologic Neoplasms 2 Thrombocytopenia 1 Sarcoma, Myeloid 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Immunoproliferative Disorders 1 Down Syndrome 1 Disease 1 Blast Crisis 1

Interventions

blinatumomab 5 Rituximab 3 Cyclophosphamide 3 Brentuximab Vedotin 3 ponatinib 2 Vincristine 2 Prednisone 2 Etoposide 2 Doxorubicin 2 tetulomab tetraxetan lu-177 1 ibritumomab tiuxetan 1 fludarabine 1 cobomarsen 1 Vorinostat 1 Melphalan 1 Lutetium 1 Imatinib Mesylate 1 Ifosfamide 1 Everolimus 1 Cytarabine 1 Carmustine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡